Han Yusheng's Form 4 filing
Burning Rock Biotech Ltd (BNR) · filed Jul 2, 2026
- Accession no.
- 0001193125-26-293511
- Filed
- Jul 2, 2026, 8:30 AM ET
- Trade date
- Jun 11-26, 2026
- Filing delay
- 21 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions. It was filed 21 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Han YushengCIK 0001843554 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +24,760 | $8.74F2 | +$216,387.54 | 17,697,436 | Direct | Price outlier |
| Jun 12, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +210,000 | $9.25F2 | +$1,942,143 | 17,907,436 | Direct | Price outlier |
| Jun 16, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +111,110 | $9.00F2 | +$999,956.67 | 18,018,546 | Direct | Price outlier |
| Jun 22, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +104,650 | $7.45F2 | +$779,673.9 | 18,123,196 | Direct | Price outlier |
| Jun 23, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +5,990 | $7.50F2 | +$44,920.21 | 18,129,186 | Direct | Price outlier |
| Jun 24, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +250,000 | $8.00F2 | +$2,000,000 | 18,379,186 | Direct | Price outlier |
| Jun 26, 2026 | Ordinary Shares (represented by American depositary shares) | PPurchaseAcquired | +24,900 | $8.00F2 | +$199,090.44 | 18,404,086 | Direct | Price outlier |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported price is the price of each ADS acquired.
Referenced by the price of 7 transactions in Table I.